FDA approves Pfizer-BioNTech COVID-19 vaccine for EUA
January 14, 2021
The Food and Drug Administration (FDA) said it has approved Pfizer-BioNTech's coronavirus vaccine for emergency use authorization (EUA).
''All conditions for the grant of EUA to Pfizer's vaccine are present,'' said FDA Director General Eric Domingo.
The EUA of two other drug companies for their COVID-19 vaccines are still being reviewed by the FDA. These are AstraZeneca and Gamaleya.
Sinovac, which the Philippines will buy for its vaccination program rollout set February, has yet to submit data on its phase 3 clinical trials to be able to apply for an EUA, said Domingo. DMS
Latest Videos
- THE UNTOLD STORY EXPERT INSIGHTS INTO THE UKRAINE
- NEGOTIATING A NEW ORDER US RUSSIA TALKS ON UKRAIN
- Ukraine: A Pawn in the Geopolitical Game? Will Trump Intervene?
- US VP VANCE CRITICIZES EUROPEAN DEMOCRACIES AT MUNICH SECURITY CONFERENCE
- UNCOVERING THE WEB OF DECEIT: CIA INFILTRATION OF THE MEDIA
- SHIFTING SANDS: TULSI GABBARD’S CONFIRMATION AND THE EVOLVING GLOBAL LANDSCAPE
- FAUCI SCANDAL: A THREAT TO GLOBAL HEALTH AND DEMOCRACY